
ViewRay VRAY
Quarterly report 2023-Q1
added 05-11-2023
ViewRay Interest Expense 2011-2026 | VRAY
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense ViewRay
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.06 M | 4.24 M | 3.31 M | 4.33 M | 7.7 M | 7.25 M | 5.95 M | 3.45 M | 2.24 M | 97 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.7 M | 97 K | 4.36 M |
Quarterly Interest Expense ViewRay
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.63 M | - | - | - | 1.06 M | - | 1.06 M | 1.06 M | 1.06 M | - | 1.07 M | 1.07 M | 1.04 M | - | 1.07 M | 1.07 M | 759 K | - | 1.97 M | 1.92 M | 1.87 M | - | 1.84 M | 1.79 M | 1.74 M | - | 1.71 M | 1.38 M | 1.08 M | - | 1.05 M | 839 K | 484 K | - | 525 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.63 M | 484 K | 1.3 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 165.05 | -6.92 % | $ 12.4 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 10.98 | -4.69 % | $ 1.65 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 105.06 | 0.47 % | $ 183 B | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.39 | 3.73 % | $ 40.1 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 34.24 | -3.13 % | $ 5.1 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 69.19 | -1.4 % | $ 102 B | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 9.18 | -2.25 % | $ 260 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Electromed
ELMD
|
78 K | $ 24.63 | 0.74 % | $ 208 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 35.38 | -3.44 % | $ 1.1 B | ||
|
Establishment Labs Holdings
ESTA
|
5.82 M | $ 55.71 | -7.01 % | $ 1.65 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.55 | 0.03 % | $ 122 M | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.92 | -4.48 % | $ 1.17 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 9.32 | -0.64 % | $ 718 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.27 | -3.54 % | $ 167 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.24 | -1.32 % | $ 3.5 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 78.78 | -4.04 % | $ 46.1 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.25 | -1.4 % | $ 1.52 B | ||
|
Penumbra
PEN
|
893 K | $ 335.11 | -0.39 % | $ 13 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.72 | -3.85 % | $ 369 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 61.25 | -3.77 % | $ 3.34 B | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
99 K | - | 10.0 % | $ 610 K | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.44 | -1.32 % | $ 1.24 B | ||
|
Myomo
MYO
|
-668 K | $ 0.67 | -1.56 % | $ 28 M |